Navigation Links
Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
Date:12/28/2009

REDWOOD CITY, Calif., Dec. 28 /PRNewswire/ -- Codexis, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to the proposed initial public offering of shares of its common stock. The shares of common stock to be sold in this offering are proposed to be sold by Codexis, Inc. and certain of its stockholders.

Credit Suisse Securities (USA) LLC and Goldman, Sachs & Co. will be acting as joint book-running managers, with RBC Capital Markets Corporation and Pacific Crest Securities LLC acting as co-managers for the offering. This offering will be made only by means of a prospectus. Copies of the preliminary prospectus for this offering may be obtained, when available, from the prospectus department of Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, New York 10010, via telephone at 1-800-221-1037; or from the prospectus department of Goldman, Sachs & Co., Attention: Prospectus Department, 85 Broad Street, New York, New York 10004, via telephone at 1-866-471-2526 or via fax at 212-902-9316.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall neither constitute an offer to sell nor a solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

About Codexis

Codexis, Inc. is a leading provider of optimized biocatalysts that make existing industrial processes faster, cleaner and more efficient than current methods and has the potential to make new industrial processes possi
'/>"/>

SOURCE Codexis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
4. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
7. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
8. FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)
9. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
10. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
11. deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimers and Other Cognitive Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... MILFORD, Mass. , May 23, 2013  Spring ... for the treatment of viral infections, today announced that ... of SB 9200, its investigational, once daily, oral therapy ... conducted in healthy, HCV-infected patients and is designed to ... 9200. SB 9200 is a first-in-class drug for the ...
(Date:5/23/2013)... , May 23, 2013   Direct to ... mastectomy is an appropriate option for many women ... surgically reduce their breast cancer risk, or with ... expansion process and a second surgery to insert ... the same surgery as mastectomy can be a ...
(Date:5/23/2013)... BALTIMORE , May 23, 2013  Ameritox, ... been selected by Progressive Medical, Inc. to become ... to help clients manage pharmacy costs and improve ... Progressive Medical, a leading pharmacy benefit manager in ... its overall medication compliance and pain management strategy ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3
... Australia, Aug. 31 What and When Data ... poster,format at worldsleep07: The 5th World Congress of the World ... in Cairns, Australia,September 2-6, 2007. This large clinical study demonstrated ... up to six months versus,placebo in adult patients with chronic ...
... Aug. 31 Oncology,focused pharmaceutical development company ... completed a Phase II clinical trial evaluating ... cancer cells from an,autologous graft in bone ... from the clinical study revealed improved overall ...
Cached Medicine Technology:New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia 2New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia 3Kiadis Pharma Announces Promising Phase II Clinical Trial Results for Reviroc 2
(Date:5/23/2013)... 23, 2013 Hile Design LLC is ... was awarded a Silver Creative Award at the Summit ... winning entry was for its “Open Doors” animation promoting ... Show” in the 2013 District 6 ADDY Awards for ... Summit Creative Award recognizes and celebrates the creative achievements ...
(Date:5/23/2013)... 2013 Fresh Healthy Vending is a ... with healthy food and drinks in locations such as ... full-service marketing and advertising department has a goal of ... for their franchisees, and to promote the Fresh Healthy ... in many leading publications and TV networks across the ...
(Date:5/23/2013)... May 23, 2013 Jim Fitzpatrick just ... Fitzpatrick Advertising developed yet another outside-of-the-box approach to reaching ... News.com, he brings daily newscasts to the retail automotive ... delivery of a broadcast news format. , CBTNews.com ... automotive news. Co-anchors Bridget Everett and Russell Brown host ...
(Date:5/23/2013)... Springs, FL (PRWEB) May 23, 2013 The ... about redefining retirement. Many Americans are facing a dim life ... the Late Boomers -- those born after 1955 -- carry ... card debt. But all hope for The Golden Years is ... how to reduce debt and keep earning after reaching the ...
(Date:5/23/2013)... that can cause rapidly progressing, life threatening meningitis and ... we have not known how it attaches to the ... it attaches to the airway to colonise", People can ... symptoms, while some people progress to invasive disease. ... of how the bacterium colonises the airway. Now that ...
Breaking Medicine News(10 mins):Health News:Fresh Healthy Vending Receives Recent National and Local Media Focus 2Health News:Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News 2Health News:Viewpoints with Terry Bradshaw Presents a Series on Redefining Retirement 2Health News:New discovery in fight against deadly meningococcal disease 2
... VaniqaT is a prescription drug which was approved by the ... treating excessive facial hair ,in women, which is often part ... alternative for women for whom this problem is considered ... once a ,week for hair removal. Vaniqa is actually ...
... can be regenerated using stem cells from blood -- ... grow their own liver transplants using bone marrow. This adds ... as "master cells" because they can produce a variety of ... create custom-grown organ transplants. , , ,"The liver is an ...
... in Dallas soon report that amphetamines may speed up the ... , ,This study was done on patients who had suffered from ... oxygen to the brain., , ,Amphetamines were given to 30 stroke ... while they don't know for sure until the results are finalized, ...
... symptoms of depression are at an increased risk of stroke, ... Prevention. In particular, depressed African Americans showed the largest ... levels of depression had a 73% increase in their risk ... actually caused the stroke, or if some unknown factor related ...
... the AIDS crisis ravaging sub-Saharan Africa dominates much of the ... and AIDS workers are sounding the alarm for what many ... very serious catastrophe in the offing, and if there's an ... it's not any of the other superpowers--the big threat to ...
... from June issue of the American Journal of Epidemiology ... rates than taller people from most causes except cancer. ... women undertaken by Dr.Pekka Jousilahti and his colleagues from ... was found that there was an association between adult ...
Cached Medicine News:
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
... The integration of Trabecular Metal ... implant design results in a fusion ... only meets surgeon demands for initial ... a wide variety of shell and ...
The Trilogy system builds on the success of the Harris/Galante Porous and HGP II cups by combining proven features with new technology designed to inhibit the formation and migration of polyethylene ...
For primary and revision cases...
Medicine Products: